🟢 Rocket Pharmaceuticals is trading 7.61% up in pre-market with no clear catalyst identified

Rocket Pharmaceuticals is trading 7.61% up in pre-market at $3.91 after rising from the September 09, 2026 close of $3.63, with no fresh company announcement or explicit news-based explanation identified.

• The company is scheduled to participate in the Cantor Global Healthcare Conference on September 10, 2026, at 1:00 p.m. ET.
• Available reports do not directly link the conference to the price increase.
• Broader futures are mixed, limiting macro attribution.